South Korea · Delayed Price · Currency is KRW JW Pharmaceutical Statistics
Total Valuation
KRX:001060 has a market cap or net worth of KRW 601.33 billion. The enterprise value is 589.14 billion.
| Market Cap | 601.33B |
| Enterprise Value | 589.14B |
Important Dates
The next estimated earnings date is Friday, August 14, 2026.
| Earnings Date | Aug 14, 2026 |
| Ex-Dividend Date | Mar 31, 2026 |
Share Statistics
KRX:001060 has 22.89 million shares outstanding. The number of shares has decreased by -9.26% in one year.
| Current Share Class | 22.55M |
| Shares Outstanding | 22.89M |
| Shares Change (YoY) | -9.26% |
| Shares Change (QoQ) | +12.14% |
| Owned by Insiders (%) | 0.81% |
| Owned by Institutions (%) | 8.38% |
| Float | 12.90M |
Valuation Ratios
The trailing PE ratio is 8.42.
| PE Ratio | 8.42 |
| Forward PE | n/a |
| PS Ratio | 0.76 |
| PB Ratio | 1.58 |
| P/TBV Ratio | 1.63 |
| P/FCF Ratio | 8.06 |
| P/OCF Ratio | 7.05 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 4.88, with an EV/FCF ratio of 7.90.
| EV / Earnings | 8.34 |
| EV / Sales | 0.75 |
| EV / EBITDA | 4.88 |
| EV / EBIT | 5.80 |
| EV / FCF | 7.90 |
Financial Position
The company has a current ratio of 1.46, with a Debt / Equity ratio of 0.14.
| Current Ratio | 1.46 |
| Quick Ratio | 0.86 |
| Debt / Equity | 0.14 |
| Debt / EBITDA | 0.46 |
| Debt / FCF | 0.73 |
| Interest Coverage | 22.48 |
Financial Efficiency
Return on equity (ROE) is 20.07% and return on invested capital (ROIC) is 19.20%.
| Return on Equity (ROE) | 20.07% |
| Return on Assets (ROA) | 10.08% |
| Return on Invested Capital (ROIC) | 19.20% |
| Return on Capital Employed (ROCE) | 24.24% |
| Weighted Average Cost of Capital (WACC) | 9.16% |
| Revenue Per Employee | 739.65M |
| Profits Per Employee | 66.16M |
| Employee Count | 1,068 |
| Asset Turnover | 1.28 |
| Inventory Turnover | 3.52 |
Taxes
In the past 12 months, KRX:001060 has paid 29.66 billion in taxes.
| Income Tax | 29.66B |
| Effective Tax Rate | 29.31% |
Stock Price Statistics
The stock price has increased by +12.21% in the last 52 weeks. The beta is 0.95, so KRX:001060's price volatility has been similar to the market average.
| Beta (5Y) | 0.95 |
| 52-Week Price Change | +12.21% |
| 50-Day Moving Average | 29,722.00 |
| 200-Day Moving Average | 27,365.00 |
| Relative Strength Index (RSI) | 38.57 |
| Average Volume (20 Days) | 69,722 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, KRX:001060 had revenue of KRW 789.95 billion and earned 70.66 billion in profits. Earnings per share was 3,129.32.
| Revenue | 789.95B |
| Gross Profit | 373.59B |
| Operating Income | 99.45B |
| Pretax Income | 101.18B |
| Net Income | 70.66B |
| EBITDA | 118.54B |
| EBIT | 99.45B |
| Earnings Per Share (EPS) | 3,129.32 |
Balance Sheet
The company has 66.32 billion in cash and 54.12 billion in debt, with a net cash position of 12.19 billion or 532.80 per share.
| Cash & Cash Equivalents | 66.32B |
| Total Debt | 54.12B |
| Net Cash | 12.19B |
| Net Cash Per Share | 532.80 |
| Equity (Book Value) | 381.78B |
| Book Value Per Share | 15,808.24 |
| Working Capital | 97.54B |
Cash Flow
In the last 12 months, operating cash flow was 85.32 billion and capital expenditures -10.73 billion, giving a free cash flow of 74.59 billion.
| Operating Cash Flow | 85.32B |
| Capital Expenditures | -10.73B |
| Depreciation & Amortization | 19.09B |
| Net Borrowing | -27.71B |
| Free Cash Flow | 74.59B |
| FCF Per Share | 3,258.85 |
Margins
Gross margin is 47.29%, with operating and profit margins of 12.59% and 9.05%.
| Gross Margin | 47.29% |
| Operating Margin | 12.59% |
| Pretax Margin | 12.81% |
| Profit Margin | 9.05% |
| EBITDA Margin | 15.01% |
| EBIT Margin | 12.59% |
| FCF Margin | 9.44% |
Dividends & Yields
This stock pays an annual dividend of 450.00, which amounts to a dividend yield of 1.72%.
| Dividend Per Share | 450.00 |
| Dividend Yield | 1.72% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 9 |
| Payout Ratio | 15.47% |
| Buyback Yield | 9.26% |
| Shareholder Yield | 11.10% |
| Earnings Yield | 11.75% |
| FCF Yield | 12.40% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on December 27, 2023. It was a forward split with a ratio of 1.02.
| Last Split Date | Dec 27, 2023 |
| Split Type | Forward |
| Split Ratio | 1.02 |
Scores
KRX:001060 has an Altman Z-Score of 3.94 and a Piotroski F-Score of 6.
| Altman Z-Score | 3.94 |
| Piotroski F-Score | 6 |